PEN Q4 2024 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$316M+10.8% YoY

Gross Profit

$211M66.8% margin

Operating Income

$43M13.6% margin

Net Income

$34M10.7% margin

EPS (Diluted)

$0.86

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

$51M

Free Cash Flow

$46M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$382M

Stockholders' Equity

$1.2B

Cash & Equivalents

$324M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$316M	$285M	+10.8%
Gross Profit	$211M	$187M	+12.7%
Operating Income	$43M	$35M	+22.1%
Net Income	$34M	$54M	-37.9%

Geographic Segments

UNITED STATES

$248M79%

Other Non-US

$68M21%